Hoechst Pakistan Limited (KASE: HPL)
Health Care · Pharmaceuticals · PK
PKRs3,961.82
-0.41% today · -3.3% 1Y
Hoechst Pakistan Limited (KASE: HPL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $137.99M.
Over the last twelve months the share price has lost 3.3%, trading between 3.60K and 4.89K.
Tweenvest scores Hoechst Pakistan Limited across four factors: quality 92/100, value 45/100, dividend 90/100. Its strongest factor is quality.
HPL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $137.99M
- Revenue (TTM)
- $112.83M
- P/E
- 10.19
- EPS
- 388.64
- Dividend yield
- 6.82%
- Beta (5Y)
- 0.17
- 52-week high
- PKRs4,889.99
- 52-week low
- PKRs3,602.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.64M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Whan In Pharm Co.,Ltd.KOSE: A016580 | $139.97M | ₩10,180.00 | -0.68% |
| Astena Holdings Co., Ltd.TSE: 8095 | $139.16M | ¥545.00 | -0.55% |
| Photocure ASAOB: PHO | $138.99M | Nkr49.50 | +0.20% |
| Kolon Life Science Inc.KOSDAQ: A102940 | $138.76M | ₩14,250.00 | -1.32% |
| Cuu Long Pharmaceutical Joint Stock CompanyHOSE: DCL | $137.70M | ₫48,800.00 | +4.95% |
| Kotra Industries BerhadKLSE: KOTRA | $137.58M | RM3.79 | -0.26% |
| BioSyent Inc.TSXV: RX | $135.93M | CA$17.15 | +1.39% |
| PT Kimia Farma TbkIDX: KAEF | $135.63M | Rp436.00 | +5.83% |
Figures last refreshed Oct 11, 2026.